Skip to content

Hypertension and exercise: an intervention study in older patients

Effect of high-intensity interval training and moderate-intensity continuous training on ambulatory blood pressure, cardiac, vascular, autonomic, cerebral, psychological, metabolic and body composition outcomes in hypertensive older adults: a randomized controlled clinical trial - HEXA: Hypertension EXercise Approaches: an intervention study in older patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4ntszb
Enrollment
Unknown
Registered
2019-04-02
Start date
2019-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

High-intensity interval training group: 22 hypertensive older adults will be submitted to an aerobic training program during 12 weeks. The program will consist of 3 sessions per week of walking/joggin
Behavioural
G11.427.410.698.277
E02.760.169.063.500.387
G11.427.410.698.277.311.250

Sponsors

Universidade Federal do Rio Grande do Norte – UFRN
Lead Sponsor
Hospital Universitário Onofre Lopes – HUOL
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Both sexes; aged 60-80 years; previous diagnosis of hypertension; self-reported and clinically assessed physical activity readiness; unchanged pharmacological plan for hypertension in the last 4 weeks; willing to engage in any of the interventions; not engaging in a regular physical activity program in the past 3 months; insufficiently active (i.e., not performing 150 min/week of moderate physical activity and/or 75 min/week of vigorous physical activity, assessed through 7-day accelerometry)

Exclusion criteria

Exclusion criteria: Being unable or refusing to sign the consent form; previous cardiovascular events or diseases (e.g. unstable angina, severe arrhythmia, acute myocardial infarction, coronary artery disease, stroke, deep vein thrombosis, peripheral artery disease, uncontrolled arrhythmia, pacemaker use, etc.); limiting chronic pulmonary disease (emphysema, chronic bronchitis, asthma); chronic kidney disease in need of dialysis; incidence of cardiovascular or pulmonary events during the study; uncontrolled hypertension (> 160/105 mmHg); diabetes with insulin use or decompensated (fasting glucose > 300 mg/dl); high alcohol intake (>14 doses per week); self-reported or perceived language, hearing or sight limitations that may come to hinder participation; exercise contraindication, as indicated on the maximum cardiopulmonary exercise test (e.g. EKG alterations suggesting myocardial ischemia); osteomioarticular issues that may prevent performing maximal cardiopulmonary exercise testing and moderate-to-vigorous aerobic exercise or osteomioarticular injury during the study (e.g. muscle injury resulting in limitations for exercise); neurological progressive disorders (Parkinson, multiple sclerosis, Alzheimer); cancer demanding treatment in the past two years

Design outcomes

Primary

MeasureTime frame
Decrease in ambulatory systolic blood pressure levels after 12 weeks of aerobic training, assessed through ambulatory blood pressure monitoring, through the confirmation of a decrease of at least 4 mmHg between pre- and post-intervention measurements compared to the control group

Secondary

MeasureTime frame
Improved brain hemodynamics in the pre-frontal cortex in response to cognitive task after 12 weeks of aerobic training, assessed through near infrared spectroscopy (NIRS) and computerized Stroop test, through the confirmation of a statistically significant decrease (p 0.05) after 12 weeks of aerobic training, assessed through triaxial accelerometry, in the pre- and post-intervention measurements compared to the control group;No significant changes in sedentary behavior (p >0.05) after 12 weeks of aerobic training, assessed through triaxial accelerometry, in the pre- and post-intervention measurements compared to the control group;No significant changes in food intake (p >0.05) after 12 weeks of aerobic training, assessed through 24-hour dietary recall questionnaire, in the pre- and post-intervention measurements compared to the control group;Decrease in ambulatory diastolic blood pressure levels after 12 weeks of aerobic training, assessed through ambulatory blood pressure monitoring, through the confirmation of a statistically significant decrease (p <0.05) between pre- and post-intervention measurements compared to the control group;Decrease in resting blood pressure levels after 12 weeks of aerobic training, assessed through an oscillometric blood pressure monitor, through the confirmation of a statistically significant decrease (p <0.05) between pre- and post-intervention measurements compared to the control group;Decrease in central arterial (aortic) resting pressure levels after 12 weeks of aerobic training, assessed through ambulatory blood pressure monitoring, through the confirmation of a statistically significant decrease (p <0.05) between pre- and post-intervention measurements compared to the control group;Decrease in resting arterial stiffness (pulse wave velocity) after 12 weeks of aerobic training, assessed through ambulatory blood pressure monitoring, through the confirmation of a statistically significant decrease (p <0.05) between pre- and post-int

Countries

Brazil

Contacts

Public ContactEduardo;Rodrigo Costa;Browne

Universidade Federal do Rio Grande do Norte - UFRN;Universidade Federal do Rio Grande do Norte – UFRN

ecc@ufrnet.br;rodrigobrowne@ufrn.edu.br+55(84)32153451;+55(84)32153451

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 5, 2026